MEDO DX Pte. Ltd.

MEDO DX Pte. Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on April 23, 2021 and the most recent on April 23, 2021 (MEDO-Thyroid). Its most common review panel is Radiology (1 device).